Julia Ritsan
Family Medicine · Middletown, NJNPI 1730178054
Payments from drug & device makers
Across 333 payments — averaging $22.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Novo Nordisk$945
- Boehringer Ingelheim$499
- AbbVie$467
- Amarin Pharma, Inc.$323
- Lilly USA, LLC$290
- plus $2K from 28 others
What the payments were for
- Food & beverage$7,457100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 103 | $3,300 |
| Novo Nordisk | 55 | $945 |
| Boehringer Ingelheim | 17 | $499 |
| AbbVie(2 entities) | 25 | $467 |
| Amarin Pharma, Inc. | 15 | $323 |
| Lilly USA, LLC | 18 | $290 |
| Pfizer | 11 | $151 |
| Kowa Pharmaceuticals America, Inc. | 10 | $130 |
| GSK | 9 | $125 |
| Merck | 8 | $108 |
| Dexcom, Inc. | 2 | $106 |
| Novartis | 5 | $98 |
| Amgen | 6 | $82 |
| Daiichi Sankyo Inc. | 4 | $81 |
| Bayer | 3 | $66 |
| Boston Scientific | 1 | $65 |
| Sanofi-aventis U.S. LLC | 4 | $53 |
| Exact Sciences | 2 | $51 |
| Astellas Pharma US Inc | 3 | $50 |
| Johnson & Johnson | 4 | $48 |
| Phadia US Inc. | 3 | $48 |
| Scilex Pharmaceuticals Inc. | 3 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Sanofi Pasteur Inc. | 3 | $41 |
| E.r. Squibb & Sons, L.L.C. | 3 | $39 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| IBSA Pharma Inc. | 2 | $31 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Genentech USA, Inc. | 2 | $28 |
| Irhythm Technologies, Inc. | 1 | $26 |
| Bardy Diagnostics, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,463 in reported general payments places this provider in the 90th percentile of 2,084 family medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam | 52 | $420 |
| Omeprazole | 14 | $210 |
| Losartan Potassium | 14 | $165 |
| Levothyroxine Sodium | 17 | $114 |
| Atorvastatin Calcium | 15 | $97 |
| Pregabalin | 11 | $86 |
| Zolpidem Tartrate | 15 | $52 |
| Clonazepam | 11 | $50 |
| Diazepam | 12 | $39 |
| Hydrochlorothiazide | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Middletown
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.